http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-402594-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0264ab149dd139d522f7f14b1a3ea9e2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-14 |
| filingDate | 1996-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74254e9b98bc847c1a2fa3115acd3281 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4effec81aa97728a3fabb74ce1d9202 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15ce5bc7a2c8b77016be03fe08701bc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_401dbaac4a9d92837e47ed95a130a780 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95b3a9477d1bd0116d7b4ecda7477e40 |
| publicationDate | 2000-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-402594-B |
| titleOfInvention | Substituted pyrazole derivatives having an affinity for the CB2 receptor, a process for their preparation and pharmaceutical compositions in which they are present |
| abstract | A compound of the formula: (I) in which: - X1 is a group -NR1R2 or a group -OR2; -g2 and g6 are each hydrogen or a (C1-C4)alkoxy; -g3 is hydrogen, a halogen atom or a (C1-C4)alkyl; -g4 is hydrogen, a halogen atom, a (C1-C4)alkyl, a (C1-C4)alkoxy, a trifluoromethyl or a (C1-C4)alkylthio; -g5 is hydrogen; -w2 and w5 are each hydrogen or a halogen atom; -w3 is hydrogen or a halogen atom; -w4 is hydrogen, a halogen atom, a trifluoromethyl, a (C1-C4)alkyl or a (C1-C4)alkoxy; -w6 is hydrogen; -when X1 is a group -NR1R2, R1 is hydrogen or a (C1-C4)alkyl; and R2 is a non-aromatic carbocyclic radical selected from 1,3,3-trimethylbicyclo[2.2.1] hept-2-yl, bicyclo[2.2.1] hept-2yl, adamant-2-yl, bicyclo[3.2.1] oct-3-yl, 2-methylcyclohex-1-yl, 2,6-dimethylcyclohex-1-yl, 2,2,6,6-tetramethylcyclohex-1-yl and 7,7-dimethylbicyclo[4.10] hept-3-yl; -when X1 is a group -OR2, R2 is a 1,3,3-trimethylbicyclo[2.2.1] hept-2-yl radical; -R3 is hydrogen or a group -CH2R6; -R4 and R5 are each hydrogen or a (C1-C4)alkyl; -or else R4 is hydrogen and R5 and w6 together constitute a trimethylene radical; and -R6 is hydrogen or a (C1-C5)alkoxy; and its salts. |
| priorityDate | 1995-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 316.